文献速递瓣膜外科

风湿性瓣膜病患者Ross手术的长期结果

Long-term results of the Ross operation in rheumatic valve disease.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

本研究对比风湿性心脏病(RHD)与二叶式主动脉瓣(BAV)患者接受Ross手术的长期结局,分析1995至2020年间147例RHD与314例BAV患者,经倾向性评分匹配后各86对。两组20年生存率及肺动脉自体移植物再手术累积发生率均无显著差异,RHD组右心同种移植物再手术在未匹配队列中较高,匹配后未达统计学显著。

要点

  • RHD与BAV患者Ross术后20年生存率在未匹配(67.8% vs 79.7%,P=0.27)和匹配队列(72.5% vs 82.9%,P=0.46)均无显著差异。
  • 肺动脉自体移植物再手术20年累积发生率在未匹配(13.4% vs 14.4%,P=0.67)和匹配队列(11.6% vs 21.1%,P=0.47)均相当。
  • 右心同种移植物再手术在未匹配队列RHD组较低(5.5% vs 16.7%,P=0.035),匹配后未达统计学显著(9.9% vs 32.3%,P=0.051)。

核心结论

  • 接受Ross手术的风湿性心脏病患者与二叶式主动脉瓣患者相比,长期生存率和再手术率相似。

研究设计与样本

  • 研究分析了1995年至2020年间接受Ross手术的风湿性病患者和二叶式主动脉瓣患者,其中风湿性疾病147例,二叶式主动脉瓣314例。
  • 采用倾向性评分分析调整基线特征差异,匹配后得到86对基线特征相似的患者。
  • 主要结局为晚期生存率以及肺动脉自体移植物和右心室同种移植物的再手术。
  • 匹配队列中事件的累积发生率采用Fine-Gray模型比较。

主要发现

  • 在未匹配人群中,风湿性疾病患者更年轻、症状更多、左心室功能更差,且术前更常诊断为主动脉瓣关闭不全。
  • 与二叶式主动脉瓣患者相比,风湿性患者在未匹配队列(风湿性心脏病=67.8% vs 二叶式主动脉瓣=79.7%,P=0.27)和匹配队列(风湿性心脏病=72.5% vs 二叶式主动脉瓣=82.9%,P=0.46)的20年生存率均相似。
  • 肺动脉自体移植物再手术的20年累积发生率在未匹配(风湿性心脏病13.4% vs 二叶式主动脉瓣14.4%,P=0.67)和匹配患者(风湿性心脏病11.6% vs 二叶式主动脉瓣21.1%,P=0.47)中均相当。
  • 仅3次检测到因风湿性受累导致的肺动脉自体移植物功能障碍。
  • 右心同种移植物再手术的累积发生率在未匹配队列中风湿性心脏病组较高(风湿性心脏病=5.5% vs 二叶式主动脉瓣=16.7%,P=0.035),但倾向性评分匹配后未达统计学显著(风湿性心脏病=9.9% vs 二叶式主动脉瓣=32.3%,P=0.051)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to evaluate the impact of rheumatic heart disease (RHD) on the long-term outcomes of the Ross operation when compared to patients with bicuspid aortic valves (BAV). METHODS AND RESULTS: We analysed patients with rheumatic disease and BAV who underwent a Ross operation between 1995 and 2020. The primary outcomes were late survival and reoperations on the pulmonary autograft and the right ventricular allograft. We also performed a propensity score analysis to adjust for differences in baseline characteristics. The cumulative incidence of the events in the matched cohorts was compared using the Fine-Gray model. There were 147 patients with rheumatic disease and 314 with bicuspid valves. In the unmatched population, patients with rheumatic disease were younger, more symptomatic, had worse left ventricular function and were more likely to present a preoperative diagnosis of aortic insufficiency. Propensity matching resulted in 86 pairs with similar baseline characteristics. Compared with those with bicuspid valves, rheumatic patients had similar 20-year survival both in the unmatched (RHD = 67.8% vs BAV = 79.7%, P = 0.27] and matched cohorts (RHD = 72.5% vs BAV = 82.9%, P = 0.46). Cumulative incidence of reoperations on the pulmonary autograft after 20 years was also comparable between them in the unmatched (RHD 13.4% vs BAV 14.4%, P = 0.67) and matched patients (RHD 11.6% vs BAV 21.1%, P = 0.47). Pulmonary autograft dysfunction due to rheumatic involvement was detected in only three occasions. Cumulative incidence of reoperations on the right-sided allograft was higher in the unmatched cohort (RHD = 5.5% vs BAV = 16.7%, P = 0.035) but became nonsignificant after propensity score matching (RHD = 9.9% vs BAV = 32.3%, P = 0.051). The cumulative incidence of all Ross-related reoperations was similar in both groups. CONCLUSIONS: Among patients undergoing Ross operation, patients with RHD had similar long-term survival and rates of reoperations, when compared to patients with BAV.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Réa ABBADC, Affonso da Costa FD, Adam EL, et al. Long-term results of the Ross operation in rheumatic valve disease. Eur J Cardiothorac Surg. 2022. PMID: 36179101. doi:10.1093/ejcts/ezac487

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。